OrthoAccel Granted 3 New Patents –2 in the U.S. and 1 in China– for Proprietary Vibratory Orthodontic Technology Used in AcceleDent

HOUSTON (May 25, 2016) – OrthoAccel® Technologies, Inc., the leader in accelerated orthodontics, announced today that it has been granted two new patents from the United States Patent and Trademark Office, and one international patent from the State Intellectual Patent Office of the People’s Republic of China, in the category of vibrating dental devices. The new patents protect key design elements and ranges of parameters for AcceleDent®, the first and only FDA-cleared vibratory orthodontic device that is clinically proven to speed up orthodontic treatment by as much as 50 percent and reduce the discomfort associated with orthodontic treatment.

OrthoAccel now holds 13 patents including these three new ones focused on its breakthrough AcceleDent product, and these patent grants further validate the distinct nature of AcceleDent’s SoftPulse Technology®.

“Our growing patent portfolio demonstrates OrthoAccel’s continued commitment to innovation that enhances orthodontic practice and improves the patient experience,” said Michael K. Lowe, president and CEO of OrthoAccel. “We’re proud to receive our first patent from China as we further expand the global footprint of accelerated orthodontics with AcceleDent.”

A Class II medical device, AcceleDent is available by prescription in more than 3,000 orthodontic locations in North America and nearly 800 international locations. Some of the industry’s leading orthodontists and their patients tout AcceleDent as the only fast, safe and gentle solution that resolves the two most common barriers to treatment – length of treatment and pain.

To use AcceleDent patients bite down on the product mouthpiece for 20 minutes daily while gentle vibrations from its patented SoftPulse Technology accelerate bone modeling and remodeling in the craniofacial region.

In addition to covering core AcceleDent design elements, the new patents support AcceleDent’s ability to store and communicate key usage information. Lowe added that a $12 million equity financing that the company recently announced will allow OrthoAccel to continue investing in innovation and further expand the company’s patent portfolio.

About OrthoAccel® Technologies, Inc.

OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company’s innovations is AcceleDent®, an FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent and reduces discomfort associated with orthodontic treatment. OrthoAccel, the Leader in Accelerated Orthodontics, has received positive feedback from patients and leading orthodontists from around the world who recommend the award-winning AcceleDent as the fast, safe and gentle solution to accelerate orthodontic treatment. Ranked on Deloitte’s 2015 Technology Fast 500 as one of the fastest growing companies in North America, OrthoAccel is based in Houston, Texas and maintains a global presence through its EMEA office in Essen, Germany. To learn more about OrthoAccel’s focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.

Media Contacts